Bal Pharma consolidated net profit declines 0.73% in the March 2025 quarter

Sales decline 13.47% to Rs 81.88 crore

Net profit of Bal Pharma declined 0.73% to Rs 5.43 crore in the quarter ended March 2025 as against Rs 5.47 crore during the previous quarter ended March 2024. Sales declined 13.47% to Rs 81.88 crore in the quarter ended March 2025 as against Rs 94.63 crore during the previous quarter ended March 2024.

For the full year,net profit declined 2.30% to Rs 7.22 crore in the year ended March 2025 as against Rs 7.39 crore during the previous year ended March 2024. Sales declined 10.65% to Rs 303.08 crore in the year ended March 2025 as against Rs 339.22 crore during the previous year ended March 2024.

Particulars	Quarter Ended			Year Ended
	Mar. 2025	Mar. 2024	% Var.	Mar. 2025	Mar. 2024	% Var.
Sales	81.88	94.63	-13	303.08	339.22	-11
OPM %	9.33	10.14	-	9.75	9.06	-
PBDT	4.77	7.91	-40	14.91	19.12	-22
PBT	2.59	5.75	-55	5.14	9.05	-43
NP	5.43	5.47	-1	7.22	7.39	-2

Powered by Capital Market - Live News